Korean J Intern Med.  2016 Jul;31(4):730-738. 10.3904/kjim.2014.328.

Liver cirrhosis leads to poorer survival in patients with end-stage renal disease

Affiliations
  • 1Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea. jhchang@gilhospital.com

Abstract

BACKGROUND/AIMS
Liver cirrhosis (LC) is an important problem in patients withend-stage renal disease (ESRD). Few studies have investigated the inf luence ofLC on mortality in patients with ESRD. This study investigated the associationbetween LC and mortality among patients with ESRD and compare mortality betweentwo dialysis modalities.
METHODS
Adult patients (≥ 18 years of age) starting dialysis for ESRD were enrolledin the present study from 2000 to 2011. We analyzed 1,069 patients withESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patientswere undergoing peritoneal dialysis (PD).
RESULTS
The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-,3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively,whereas the equivalent survival rates of cirrhotic patients were 90%,68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independentrisk factor for death in patients with ESRD. No difference in mortality associatedwith LC was found between the HD and PD subgroups.
CONCLUSIONS
Of the patients with ESRD, cirrhotic patients had poorer survivalthan noncirrhotic patients. Among patients with ESRD and LC, survival of patientsundergoing PD may be comparable with that of patients undergoing HD.

Keyword

Hemodialysis; Liver cirrhosis; Mortality; Peritoneal dialysis

MeSH Terms

Adult
Dialysis
Humans
Kidney Failure, Chronic*
Liver Cirrhosis*
Liver*
Mortality
Peritoneal Dialysis
Prevalence
Renal Dialysis
Survival Rate
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr